Clinical Trials Logo

Clinical Trial Summary

To elucidate the health effects, and further explore the research on safety. This study was conducted among adults with metabolic disease by using the intermittent fasting for 4 weeks. The aim of this study is to provide scientific basis for the IF used as a new prevention and control technology for metabolic disease.


Clinical Trial Description

In this trail, participants with metabolic disease were enrolled for 4-week intermittent fasting intervention. The intermittent fasting plains include time-restricted fasting and 5:2 project. For TRF regimen, participants are allowed to eat ad libitum from 7am to 5pm and fast in other time. For 5:2 project, chose two non-consecutive days per week to eat very little and eat ad libitum the other 5 days of the week. Serum samples and feces samples were collected before and after intervention for analysis. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT04795973
Study type Interventional
Source Beijing Chao Yang Hospital
Contact Jia Liu
Phone 01085231217
Email liujia0116@126.com
Status Recruiting
Phase N/A
Start date September 22, 2020
Completion date August 31, 2023